
Breaking the Silence on Womb Cancer: Time for Global Change
Womb (uterine) cancer is the second most common of the five gynaecological cancers globally, yet ...
READ MORE
Womb (uterine) cancer is the second most common of the five gynaecological cancers globally, yet ...
READ MORE
Peaches are so proud to be finalists at the Third Sector Awards 2025, in the ...
READ MORE
September is Gynaecological Cancer Awareness Month — a time to raise awareness of cancers that ...
READ MORE
Maya’s research on the current diagnostic pathway for postmenopausal bleeding in the UK, and how ...
READ MORE
NICE has approved the first immunotherapy combination for endometrial cancer in England. The treatment combines ...
READ MORE
Peaches Patient Voices (PPV) have been shortlisted for a Third Sector Award 2025 in the ...
READ MORE
A new treatment for patients with primary advanced or recurrent womb cancer has been advised ...
READ MORE
A new treatment for patients with a specific type of primary advanced or recurrent womb ...
READ MORE
Peaches Patient Voices connects people affected by womb cancer, whether as a patient or a ...
READ MORE
Womb cancer, also known as endometrial and uterine cancer, affects approximately 9,700 people annually, that’s ...
READ MORE
Ongoing pain and discomfort are a common concern for many women following treatment for womb ...
READ MORE
GatewayC, the free early cancer diagnosis resource by the NHS, based out of The Christie ...
READ MORE